课题基金 / 基金详情

PAMIDRONATE ON BONE DENSITY IN PATIENTS WITH CYSTIC FIBROSIS

PAMIDRONATE ON BONE DENSITY IN PATIENTS WITH CYSTIC FIBROSIS
帕米膦酸钠对囊性纤维化患者骨密度的影响
批准号：
6275050
负责人：
ROBERT M ARIS
金额：
$1.58万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6275050
关键词：
bone density clinical research cystic fibrosis drug screening /evaluation human subject human therapy evaluation osteoporosis phosphonate skeletal disorder chemotherapy skeletal pharmacology

项目摘要

项目成果

ROBERT M ARIS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The hypothesis is that pamidronate, a biphosphonate drug that inhibits bone resorption, will be efficacious in reversing bone demineralization and preventing features in CF patients. We plan to test this hypothesis in a group of CF patients who have undergone or are awaiting lung transplanation because this cohort likely represent a worst-case scenario of osteoporosis and, therefore, the chances of significant benefit from therapy are high.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bisphosphonates on Bone Mineral Density in Patients with Cystic Fibrosis
The Effects of Alendronate on Bone Metabolism in Patients with CF
EFFECTS OF ALENDRONATE ON BONE METABOLISM IN PATIENTS WITH CYSTIC FIBROSIS
PAMIDRONATE ON BONE DENSITY IN PATIENTS WITH CYSTIC FIBROSIS
海外基金